Volume | 2 167 827 |
|
|||||
Actualités | - | ||||||
Maximum Haut | 0,187 | Bas Haut |
|||||
Minimum Bas | 0,1661 |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Qualigen Therapeutics Inc | QLGN | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
0,1685 | 0,1661 | 0,187 | 0,1771 | 0,187 |
Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
---|---|---|---|---|---|
2 598 | 2 167 827 | US$ 0,1697241 | US$ 367 932 | - | 0,1449 - 1,26 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
01:59:49 | formt | 500 | US$ 0,17 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
2,33M | 5,18M | - | 0 | -13,42M | -2,59 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Qualigen Therapeutics
Date | Heure | Source | Titre |
---|---|---|---|
30/5/2024 | 22:00 | Edgar (US Regulatory) | Form 8-K - Current report |
30/5/2024 | 22:00 | GlobeNewswire Inc. | Qualigen Therapeutics, Inc. Received Nasdaq Notice of a.. |
14/5/2024 | 22:05 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form.. |
04/5/2024 | 02:59 | Edgar (US Regulatory) | Form S-1/A - General form for registration of securities.. |
16/4/2024 | 13:00 | GlobeNewswire Inc. | Marizyme Enters Into Co-Development Agreement With Qualigen.. |
10/4/2024 | 14:00 | GlobeNewswire Inc. | Qualigen Therapeutics' Novel Direct Pan-RAS Inhibitors.. |
09/4/2024 | 14:00 | GlobeNewswire Inc. | Qualigen Therapeutics Announces Poster Featuring Positive.. |
27/2/2024 | 13:00 | Edgar (US Regulatory) | Form 8-K - Current report |
22/2/2024 | 22:10 | Edgar (US Regulatory) | Form 8-K - Current report |
07/12/2023 | 22:15 | Edgar (US Regulatory) | Form 8-K - Current report |
22/11/2023 | 22:30 | Edgar (US Regulatory) | Form 8-K - Current report |
14/11/2023 | 22:30 | GlobeNewswire Inc. | Qualigen Therapeutics Provides Corporate Update for Third.. |
Forum Action Qualigen Therapeutics
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Qualigen Therapeutics Inc
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 0,21 | 0,2365 | 0,1449 | 0,1867702 | 7 191 678 | -0,04 | -19,05% |
1 mois | 0,287 | 0,33 | 0,1449 | 0,196791 | 1 887 822 | -0,117 | -40,77% |
3 mois | 0,39 | 0,445 | 0,1449 | 0,207783 | 655 712 | -0,22 | -56,41% |
6 mois | 0,5625 | 0,61 | 0,1449 | 0,2318153 | 332 485 | -0,3925 | -69,78% |
1 an | 0,95 | 1,26 | 0,1449 | 0,2756079 | 174 865 | -0,78 | -82,11% |
3 ans | 20,00 | 31,20 | 0,1449 | 15,18 | 1 017 564 | -19,83 | -99,15% |
5 ans | 72,50 | 79,00 | 0,1449 | 23,95 | 1 114 610 | -72,33 | -99,77% |